how does glp 1 lower cholesterol Saxenda and Cholesterol: GLP-1 Evidence Explained – Bolt Pharmacy The GLP-1 Analogs Liraglutide and

Tirzepatide dosing protocol Tirzepatide follows a well-established escalation schedule refined through multiple clinical trials and years of real-world use: Weeks 1-4: 2.5 mg once weekly (starting dose) Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly (optional intermediate step) Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly (optional intermediate step) Week 21+: 15 mg once weekly (maximum dose) The starting dose of 2.5 mg is intentionally subtherapeutic

it's a dual GLP-1/GIP receptor agonist for weight loss and diabetes thats also manufactured by Eli Lilly

Thankfully, there are better, more evidence-based approaches to weight loss and blood sugar control, which well explore next